Subjects with NAFLD and NASH typically have elevated circulating concentrations of markers of liver injury, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), and γ-glutamyltransferase (GGT) [19]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.